These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4256)

  • 1. Acebultolol: basis for the prediction of effect on exercise tolerance.
    Biron P; Tremblay G
    Clin Pharmacol Ther; 1976 Mar; 19(3):333-8. PubMed ID: 4256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential antianginal responsiveness to acebutolol.
    Biron P; Tremblay G
    Eur J Clin Pharmacol; 1975; 8(1):15-9. PubMed ID: 786672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation between clinical and exercise responsiveness to beta-blockade in angina.
    Tremblay G; Biron P; Proulx A
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):508-12. PubMed ID: 32144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acebutolol in angina pectoris: objective assessment using graded treadmill testing.
    Kimchi A; Gotsman MS; Lewis BS
    Isr J Med Sci; 1978 Sep; 14(9):941-7. PubMed ID: 363642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of acebutolol in chronic stable angina using single-blind and randomized double-blind protocol.
    Lee G; DeMaria AN; Favrot L; Hermanovich J; Kozina J; Krieg P; Kimchi A; Laddu A; Mason DT
    J Clin Pharmacol; 1982; 22(8-9):371-8. PubMed ID: 6813360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acebutolol and left ventricular function: assessment by radionuclide angiography.
    Katz RJ; DiBianco R; Singh S; Bortz R; Bates HR; Sauerbrunn B; Laddu AR; Fletcher RD
    Clin Pharmacol Ther; 1981 Feb; 29(2):149-54. PubMed ID: 7460480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the beta-blocking drug acebutolol in angina pectoris.
    Rod JL; Admon D; Kimchi A; Gotsman MS; Lewis BS
    Am Heart J; 1979 Nov; 98(5):604-12. PubMed ID: 495406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta adrenergic blockade does not improve effort tolerance in patients with mitral stenosis in sinus rhythm.
    Patel JJ; Dyer RB; Mitha AS
    Eur Heart J; 1995 Sep; 16(9):1264-8. PubMed ID: 8582390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acebutolol, a new beta-receptor antagonist on heart rate and rate-pressure product in normal subjects.
    Sharma PL
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):290-7. PubMed ID: 1002366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset and duration of beta-adrenergic receptor blockade following single oral dose acebutolol hydrochloride (Sectral).
    Watson RD; Littler WA
    Br J Clin Pharmacol; 1979 Jun; 7(6):557-61. PubMed ID: 37868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative beta-blocking potencies of acebutolol and propranolol relative to plasma drug levels.
    Collett JT; Hendrickson JA; Chew CY; Shah PM; Laddu AR; Singh BN
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):473-8. PubMed ID: 6117519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dose-response relationship and duration of action of acebutolol / investigations on heart rate behaviour and ischemic ST-segment depression].
    Kober G; Mikludy R; Veidt J; Kaltenbach M
    Arzneimittelforschung; 1982; 32(8):835-9. PubMed ID: 6890361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable effects of acebutolol on exercise performance and angina in men with coronary artery disease.
    Steele P; Gold F
    Chest; 1982 Jul; 82(1):40-3. PubMed ID: 7044708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nipradilol, a new beta-blocking agent with vasodilating properties, on exercise tolerance in patients with stable effort angina: a double-blind study.
    Araki H; Hayata N; Nakamura M
    Clin Ther; 1987; 9(6):656-62. PubMed ID: 2894246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary effects of acebutolol, a "cardioselective" beta adrenergic blocking agent.
    DiBianco R; Dickie KJ; Singh S; Katz RJ; Costello RB; Gottdiene JS; Laddu AR; Fletcher RD
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):1-7. PubMed ID: 6120142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac ischemia on exercise. Effect of nifedipine and acebutolol singly and in combination (author's transl)].
    Strasser R; Klepzig H
    MMW Munch Med Wochenschr; 1981 Aug; 123(35):1303-6. PubMed ID: 6793850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
    Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocking potency and electrophysiologic effects of acebutolol.
    Singh BN; Williams R; Harrison DC
    Am Heart J; 1985 May; 109(5 Pt 2):1126-31. PubMed ID: 2859775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta-adrenergic blockade on short-term variability of blood pressure and heart rate in essential hypertension.
    Girard A; Meilhac B; Mounier-Vehier C; Elghozi JL
    Clin Exp Hypertens; 1995; 17(1-2):15-27. PubMed ID: 7735265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.